High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Vitiligo is an autoimmune condition characterized by loss of epidermal melanocytes. Using tetrameric complexes of human histocompatibility leukocyte antigen (HLA) class I to identify antigen-specific T cells ex vivo, we observed high frequencies of circulating MelanA-specific, A*0201-restricted cytotoxic T lymphocytes (A2–MelanA tetramer+ CTLs) in seven of nine HLA-A*0201–positive individuals with vitiligo. Isolated A2–MelanA tetramer+ CTLs were able to lyse A*0201-matched melanoma cells in vitro and their frequency ex vivo correlated with extent of disease. In contrast, no A2–MelanA tetramer+ CTL could be identified ex vivo in all four A*0201-negative vitiligo patients or five of six A*0201-positive asymptomatic controls. Finally, we observed that the A2–MelanA tetramer+ CTLs isolated from vitiligo patients expressed high levels of the skin homing receptor, cutaneous lymphocyte-associated antigen, which was absent from the CTLs seen in the single A*0201-positive normal control. These data are consistent with a role of skin-homing autoreactive melanocyte-specific CTLs in causing the destruction of melanocytes seen in autoimmune vitiligo. Lack of homing receptors on the surface of autoreactive CTLs could be a mechanism to control peripheral tolerance in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 2×
“HLA– peptide tetrameric complexes were synthesized as previously described (17).”
BackgroundMethodVaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862 · cited 1×
“Recently, dendritic cell-based vaccination strategies for treatment of melanoma have been accompanied by the acquisition of tumor-specific CTL responses and cutaneous depigmentation, suggesting that melanocyte-specific CTLs can play a role in melanocytic destruction (15).”
BackgroundCounting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA
Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., et al. (1998) · Science · doi:10.1126/science.279.5359.2103 · Cited by 1,383
Self-citationBrichard, V, Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., & Boon, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.489 · Cited by 950
Coulie, P. G., Brichard, V, Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.35 · Cited by 903
Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., & Rosenberg, S. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.347 · Cited by 862
Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., & Slingluff, C. L. (1994) · Science · doi:10.1126/science.7513441 · Cited by 824
Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells
Fuhlbrigge, R. C., Kieffer, J. D., Armerding, D., & Kupper, T. S. (1997) · Nature · doi:10.1038/40166 · Cited by 577
Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996. 274: 94-96.
Altman, J. D., Moss, P. A. H., Goulder, P., Barouch, D. H., McHeyzer‐Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (2011) · PubMed · Cited by 572
Cited by
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P. D., et al. (1999) · Nature Medicine · doi:10.1038/9525 · Cited by 1,113
van Elsas, A., Hurwitz, A. A., & Allison, J. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.355 · Cited by 1,020
Sutmuller, R. P. M., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N. M., Wildenberg, M. E., Allison, J. P., Toes, R. E. M., Offringa, R., & Melief, C. J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.823 · Cited by 1,008
“Our observations in this murine melanoma model are reminiscent of recent reports that describe the presence of circulating melanoma/melanocyte antigen-specific CTLs in the blood of healthy human beings, although it should be noted that these latter CTLs appeared to have a naive rather than an antigen-experienced pheno…”
ResultImmune surveillance in the skin: mechanisms and clinical consequences
Kupper, T. S., & Fuhlbrigge, R. C. (2004) · Nature Reviews Immunology · doi:10.1038/nri1310 · Cited by 805
Bergqvist, C., & Ezzedine, K. (2020) · Dermatology · doi:10.1159/000506103 · Cited by 799
Vitiligo: A comprehensive overview
Alikhan, A., Felsten, L. M., Daly, M., & Petronic-Rosic, V. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.061 · Cited by 708
Vitiligo: Mechanisms of Pathogenesis and Treatment
Frisoli, M. L., Essien, K., & Harris, J. E. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100919-023531 · Cited by 618
Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients
van den Boorn, J. G., Konijnenberg, D., Dellemijn, T. A. M., Wietze van der Veen, J. P., Bos, J. D., Melief, C. J. M., Vyth-Dreese, F. A., & Luiten, R. M. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.32 · Cited by 543
Rashighi, M., Agarwal, P., Richmond, J. M., Harris, T. H., Dresser, K., Su, M.-W., Zhou, Y., Deng, A., Hunter, C. A., Luster, A. D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007811 · Cited by 518
Pittet, M. J., Valmori, D., Dunbar, P. R., Speiser, D. E., Liénard, D., Lejeune, F., Fleischhauer, K., Cerundolo, V., Cerottini, J.-C., & Romero, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.705 · Cited by 508
Self-citationNew discoveries in the pathogenesis and classification of vitiligo
Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., & Harris, J. E. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.10.048 · Cited by 476
Evidence for an Autoimmune Pathogenesis of Vitiligo
Ongenae, K., Van Geel, N., & Naeyaert, J. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00023.x · Cited by 437
Melanocyte Destruction after Antigen-Specific Immunotherapy of Melanoma
Yee, C., Thompson, J. A., Roche, P., Byrd, D. R., Lee, P. P., Piepkorn, M., Kenyon, K., Davis, M. M., Riddell, S. R., & Greenberg, P. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1637 · Cited by 428
Harris, J. E., Harris, T. H., Weninger, W., John Wherry, E., Hunter, C. A., & Turka, L. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.463 · Cited by 389
Mackensen, A., Herbst, B., Chen, J.-L., K�hler, G., Noppen, C., Herr, W., Spagnoli, G. C., Cerundolo, V., & Lindemann, A. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000501)86:3<385::aid-ijc13>3.0.co;2-t · Cited by 345
Self-citationPicardo, M., Dell'Anna, M. L., Ezzedine, K., Hamzavi, I., Harris, J. E., Parsad, D., & Taieb, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.11 · Cited by 326
van Elsas, A., Sutmuller, R. P. M., Hurwitz, A. A., Ziskin, J., Villasenor, J., Medema, J.-P., Overwijk, W. W., Restifo, N. P., Melief, C. J. M., Offringa, R., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.481 · Cited by 309
Mechanisms of melanocyte death in vitiligo
Chen, J., Li, S., & Li, C. (2021) · Medicinal Research Reviews · doi:10.1002/med.21754 · Cited by 307
Self-citationAnatomically distinct fibroblast subsets determine skin autoimmune patterns
Xu, Z., Chen, D., Hu, Y., Jiang, K., Huang, H., Du, Y., Wu, W., Wang, J., Sui, J., Wang, W., et al. (2022) · Nature · doi:10.1038/s41586-021-04221-8 · Cited by 305
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo
Richmond, J. M., Strassner, J. P., Zapata, L., Garg, M., Riding, R. L., Refat, M. A., Fan, X., Azzolino, V., Tovar-Garza, A., Tsurushita, N., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7710 · Cited by 301
A Critical Appraisal of Vitiligo Etiologic Theories. Is Melanocyte Loss a Melanocytorrhagy?
Gauthier, Y., Andre, M. C., & Taïeb, A. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00070.x · Cited by 299
Lee, K.-H., Wang, E., Nielsen, M.-B., Wunderlich, J., Migueles, S., Connors, M., Steinberg, S. M., Rosenberg, S. A., & Marincola, F. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6292 · Cited by 285
Development of αβ T cells in the human thymus
Spits, H. (2002) · Nature Reviews Immunology · doi:10.1038/nri913 · Cited by 279
Vitiligo: A focus on pathogenesis and its therapeutic implications
Bergqvist, C., & Ezzedine, K. (2021) · The Journal of Dermatology · doi:10.1111/1346-8138.15743 · Cited by 277
Local Immune Response in Skin of Generalized Vitiligo Patients
van den Wijngaard, R., Wankowicz-Kalinska, A., Le Poole, C., Tigges, B., Westerhof, W., & Das, P. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780138 · Cited by 272
Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy
Boniface, K., Seneschal, J., Picardo, M., & Taïeb, A. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8622-7 · Cited by 272
The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity
Wang, R.-F. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01896-8 · Cited by 266
Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3
Boniface, K., Jacquemin, C., Darrigade, A.-S., Dessarthe, B., Martins, C., Boukhedouni, N., Vernisse, C., Grasseau, A., Thiolat, D., Rambert, J., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.08.038 · Cited by 263
Wańkowicz-Kalińska, A., van den Wijngaard, R. M. J. G. J., Tigges, B. J., Westerhof, W., Ogg, G. S., Cerundolo, V., Storkus, W. J., & Das, P. K. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000069521.42488.1b · Cited by 262
Self-citationCollier, J. L., Weiss, S. A., Pauken, K. E., Sen, D. R., & Sharpe, A. H. (2021) · Nature Immunology · doi:10.1038/s41590-021-00949-7 · Cited by 237
Innate immune mechanisms in vitiligo: danger from within
Richmond, J. M., Frisoli, M. L., & Harris, J. E. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.10.010 · Cited by 225
“These signals function as DAMPs to activate dendritic cells [6] and subsequent priming of CD8+ T-cells for autoimmune attack of melanocytes [7].”
BackgroundCellular and developmental aspects of androgenetic alopecia
Jahoda, C. A. B. (1998) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00666.x · Cited by 192
Tracking T cells with tetramers: new tales from new tools
Klenerman, P., Cerundolo, V., & Dunbar, P. R. (2002) · Nature Reviews Immunology · doi:10.1038/nri777 · Cited by 190
Self-citationAnichini, A., Molla, A., Mortarini, R., Tragni, G., Bersani, I., Di Nicola, M., Gianni, A. M., Pilotti, S., Dunbar, R., Cerundolo, V., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.651 · Cited by 190
“654 Expanded T Cell Population to Melan-A/Mart-1 synthesized as described (18).”
MethodSelf-citationKumar Srivastava, A., Khare, P., Kumar Nagar, H., Raghuwanshi, N., & Srivastava, R. (2016) · Current Protein & Peptide Science · doi:10.2174/1389203717666151201192247 · Cited by 184
Vitiligo, reactive oxygen species and T-cells
Glassman, S. J. (2011) · Clinical Science · doi:10.1042/cs20090603 · Cited by 175
Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer
Jager, D., Jager, E., & Knuth, A. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.9.669 · Cited by 168
“50 These findings indicate that CTL responses against self antigens may occur spontaneously, and might be amplified by appropriate vaccination.”
BackgroundStrategies for immunotherapy of cancer
Melief, C. J. M., Toes, R. M., Medema, J. P., Van Der Burg, S. H., Ossendorp, F., & Offringa, R. (2000) · Advances in Immunology · doi:10.1016/s0065-2776(00)75006-1 · Cited by 165
Faraj, S., Kemp, E. H., & Gawkrodger, D. J. (2022) · Clinical and Experimental Immunology · doi:10.1093/cei/uxab002 · Cited by 94
Gargiulo, L., Papaioannou, M., Sica, M., Talini, G., Chaidos, A., Richichi, B., Nikolaev, A. V., Nativi, C., Layton, M., de la Fuente, J., et al. (2013) · Blood · doi:10.1182/blood-2012-11-469353 · Cited by 89
Zareie, P., Weiss, E. S., Kaplan, D. H., & Mackay, L. K. (2025) · Nature Immunology · doi:10.1038/s41590-025-02145-3 · Cited by 29
Metadata
- Authors
- Ogg, G. S., Rod Dunbar, P., Romero, P., Chen, J.-L., & Cerundolo, V.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-09-21
- Volume
- 188
- Issue
- 6
- Pages
- 1203-1208
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2159703967
- Cited by
- 460
- References
- 26
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.